Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis
- PMID: 38146178
- PMCID: PMC10752096
- DOI: 10.1177/00469580231218625
Comprehensive Pharmacist-led Transitions-of-care Medication Management around Hospital Discharge Adds Modest Cost Relative to Usual Care: Time-and-Motion Cost Analysis
Abstract
Optimal medication management is important during hospitalization and at discharge because post-discharge adverse drug events (ADEs) are common, often preventable, and contribute to patient harms, healthcare utilization, and costs. Conduct a cost analysis of a comprehensive pharmacist-led transitions-of-care medication management intervention for older adults during and after hospital discharge. Twelve intervention components addressed medication reconciliation, medication review, and medication adherence. Trained, experienced pharmacists delivered the intervention to older adults with chronic comorbidities at 2 large U.S. academic centers. To quantify and categorize time spent on the intervention, we conducted a time-and-motion analysis of study pharmacists over 36 sequential workdays (14 519 min) involving 117 patients. For 40 patients' hospitalizations, we observed all intervention activities. We used the median minutes spent and pharmacist wages nationally to calculate cost per hospitalization (2020 U.S. dollars) from the hospital perspective, relative to usual care. Pharmacists spent a median of 66.9 min per hospitalization (interquartile range 46.1-90.1), equating to $101 ($86 to $116 in sensitivity analyses). In unadjusted analyses, study site was associated with time spent (medians 111 and 51.8 min) while patient primary language, discharge disposition, number of outpatient medications, and patient age were not. In this cost analysis, comprehensive medication management around discharge cost about $101 per hospitalization, with variation across sites. This cost is at least an order of magnitude less than published costs associated with ADEs, hospital readmissions, or other interventions designed to reduce readmissions. Work is ongoing to assess the current intervention's effectiveness.
Keywords: adverse drug event; cost and cost analysis; hospital pharmacy service; medication management; patient discharge.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.Int J Clin Pharm. 2018 Oct;40(5):1154-1164. doi: 10.1007/s11096-018-0650-8. Epub 2018 May 12. Int J Clin Pharm. 2018. PMID: 29754251 Clinical Trial.
-
Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge.Am J Manag Care. 2016 Oct;22(10):654-661. Am J Manag Care. 2016. PMID: 28557517
-
Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study).J Hosp Med. 2016 Jan;11(1):39-44. doi: 10.1002/jhm.2493. Epub 2015 Oct 5. J Hosp Med. 2016. PMID: 26434752 Clinical Trial.
-
Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review.J Pharm Pract. 2023 Jun;36(3):668-678. doi: 10.1177/08971900211064155. Epub 2021 Dec 28. J Pharm Pract. 2023. PMID: 34962844 Free PMC article.
-
Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.BMJ Open Qual. 2022 Mar;11(1):e001560. doi: 10.1136/bmjoq-2021-001560. BMJ Open Qual. 2022. PMID: 35241436 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical